Bob Löwenberg is Professor of Hematology at Erasmus University in Rotterdam, Netherlands. Professor Löwenberg’s research activities are in the treatment and the pathobiology of leukemia. He has extensively published (~700 publications, 17,000 citations) in the area of developmental diagnostics and therapeutics in leading scientific journals.

     Bob Löwenberg has hold various leading positions. He is on the editorial board of a number of international journals, including The New England Journal of Medicine and he is section editor for Acute Leukemia for UptoDate. He is one of the founders of the Dutch-Belgian HOVON Cooperative Group and currently he is the chair of the HOVON leukemia trial group. He is the chairman of the International Scientific Advisory Board (ISAB) of BMM.

     As of January 1, 2013 Bob Löwenberg has taken up the role as the first non-American Editor-in-Chief of the Blood Journal.

     Bob Lowenberg is an elected member of the Royal Academy of Sciences and Arts of The Netherlands. Bob Lowenberg has been awarded the Dr P. Muntendam Dutch Cancer Prize (2004), the Jacqueline Seroussi Memorial Cancer Research Award (Tel Aviv, 2006), the Bob Pinedo Cancer Prize (Amsterdam, 2008), Celgene Career Achievement Award for Clinical Research in Hematology (Orlando, 2010), the Erasmus University Medical Center Award (Rotterdam, 2011) and the EHA Jean Bernard Lifetime Award (European Haematology Association, London, 2011) for his contributions to hematology and his scientific achievements in leukemia.